Associate Professor, N.1 Institute For Health, Integrative Sciences and Engineering
Jt Appt - Associate Professor, N.1 Institute for Health, N.1 Institute for Health
Jt Appt - Professor, N.1 Institute for Health, N.1 Institute for Health
Bachelor of Medicine, Bachelor of Surgery, University of Oxford, United Kingdom
Bachelor of Arts, University of Cambridge, United Kingdom
As a Clinician-Scientist and Singapore Translational Research Award Investigator, my area of dementia research, of particular importance to Singapore and Asia, is Vascular and Neurodegenerative Mechanisms in Dementia. Vascular disease is prominent among ethnic Asian dementia patients. Compared to Caucasian populations, a higher prevalence of Vascular Dementia has been reported in Asian countries such as Japan and China. Moreover, studies have revealed a vascular basis contributing to the etiology and pathogenesis of Alzheimer’s Disease. The identification of biomarkers for vascular and neurodegenerative mechanisms, and insights into the mechanisms of interaction may lead to potential therapeutic approaches.
This will not only give rise to novel scientific insights and advances but also be of immense potential benefit to Singaporeans and the biomedical industry since the increasing numbers of patients suffering from dementia exact a massive toll in health care costs, disability and lost productivity for both patients and caregivers.
2006 – 2021 Senior Clinician Scientist Award, Biomedical & National Medical Research Councils Singapore
2007 Lilly-NUS/Singapore Institute for Clinical Sciences Joint Fellow Investigational Medicine Award
2010 Glaxo Smith Kline Academic Centre of Excellence Award
2021-present Singapore Translational Research Investigator Award, National Medical Research Council
Core Research Interest and Projects:
1) Neurochemistry, Molecular Pathology and Biomarker Discovery
2) Dementia Neuroimaging using Multi-Modal Magnetic Resonance and Retinal Imaging
3) Artificial Intelligence applied to Biomarker Research
4) Epidemiology of Dementia in Singapore: Ethnicity and Risk Factors
5) Clinical Trials for Cognitive Impairment and Dementia